Search

Your search keyword '"Muga, R."' showing total 387 results

Search Constraints

Start Over You searched for: Author "Muga, R." Remove constraint Author: "Muga, R."
387 results on '"Muga, R."'

Search Results

1. Hepatitis C infection substantially reduces survival of alcohol-dependent patients

4. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

5. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

8. Imputación del instante de seroconversión al VIH en cohortes de hemofílicos

11. Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use

12. Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence A Systematic Review and Meta-analysis

13. Sex-specific Associations of Alcohol Withdrawal in Patients Admitted for the Treatment of Alcohol Use Disorder

16. Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment

17. DSM-5 in patients seeking their first treatment for alcohol use disorder. Sex differences in the multicenter CohRTA study

18. Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder

19. MDMA interactions with pharmaceuticals and drugs of abuse

24. Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection

25. Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015

26. Effect of incident hepatitis C infection on CD4 cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort

27. Effect of incident hepatitis C infection on CD4(+) cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort

28. Five-Year Incidence of Hospital-Based Emergencies Related to Acute Recreational Intoxication in Minors

30. Epidemiology of HIV-2 infection in Spain

33. Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion

34. Cannabinoids: from pot to lab

35. Key interindividual determinants in MDMA pharmacodynamics

37. Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older

42. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?

43. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?

44. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

45. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

47. Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries

48. Effect of HCV Infection on Cause-Specific Mortality After HIV Seroconversion, Before and After 1997

49. Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts

50. All-cause mortality in the cohorts of the Spanish AIDS Rearch Network (RIS) compared with the general population: 1997-2010

Catalog

Books, media, physical & digital resources